Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE. [PDF]
Tran NT +6 more
europepmc +1 more source
Crohn's disease and ulcerative colitis in β-thalassemia major: A report of two cases and a brief review of the literature. [PDF]
Amin TA +10 more
europepmc +1 more source
A review of genetic modification for ex vivo cellular therapies
Transfusion, Volume 66, Issue S2, Page S45-S57, September 2026.
Anh Dinh, Nan Zhang, David Stroncek
wiley +1 more source
Co-Occurring Genetic Mutations in Rett Syndrome and <i>MECP2</i>-Related Disorders-Clinical and Diagnostic Implications from a Case Series. [PDF]
Singh J, Chishti S, Santosh P.
europepmc +1 more source
The Splenectomy Paradox in Thalassemia: Reduced Transfusion Requirements vs. Accelerated Hepatic Fibrogenesis. [PDF]
Padeniya P +5 more
europepmc +1 more source
Protecting against genetic discrimination requires more than a law. [PDF]
The Lancet Regional Health-Western Pacific.
europepmc +1 more source
Haemoglobin D-Punjab haemoglobinopathy, the silent epidemic: A prospective hospital based study in Gujarat, India. [PDF]
Anandani G +5 more
europepmc +1 more source
Outcomes with luspatercept in patients with β-thalassemia: a systematic review and meta-analysis. [PDF]
Babiker N +9 more
europepmc +1 more source
Evaluating compliance with restrictive blood transfusion practices: A 5-year study from a Greek tertiary hospital. [PDF]
Nikolopoulos GK +13 more
europepmc +1 more source

